A proof-of-concept study: Mirabegron, a new therapy for overactive bladder-Reference-Cited by-同舟云学术

A proof-of-concept study: Mirabegron, a new therapy for overactive bladder

Published:2013-02-19 Issue:8 Volume:32 Page:1116-1122
ISSN:0733-2467
Container-title:Neurourology and Urodynamics
language:en
Short-container-title:Neurourol. Urodynam.

Author:

Chapple Christopher R.¹,Amarenco Gerard²,López Aramburu Miguel A.³,Everaert Karel⁴,Liehne Josef⁵,Lucas Malcolm⁶,Vik Viktor⁷,Ridder Arwin⁸,Snijder Robert⁸,Yamaguchi Osamu⁹,

Affiliation:

1. Department of Urology, Royal Hallamshire Hospital; Sheffield Teaching Hospitals; Sheffield UK

2. Department of Neurourology; Hôpital Tenon; Paris France

3. Servicio de Urologia; Hospital Santiago Apostol; Miranda de Ebro (Burgos) Spain

4. Department of Urology; Ghent University Hospital; Ghent Belgium

5. Ustecke Urocentrum; Ústí nad Labem; Czech Republic

6. ABMU Local Health Board; Morriston Hospital; Swansea UK

7. Tomayerova Nemocnice; Prague Czech Republic

8. Astellas Pharma Europe BV; Leiden Netherlands

9. Division of Bioengineering and LUTD Research, School of Engineering; Nihon University; Koriyama Japan

Publisher

Wiley

Subject

Urology,Neurology (clinical)

Reference17 articles.

1. The standardisation of terminology of lower urinary tract function: Report from the Standardisation Sub-committee of the International Continence Society;Abrams;Neurourol Urodyn,2002

2. The overlap of storage, voiding and postmicturition symptoms and implications for treatment seeking in the USA, UK and Sweden: EpiLUTS;Sexton;BJU Int,2009

3. Basic mechanisms of urgency: Preclinical and clinical evidence;Michel;Eur Urol,2009

4. Muscarinic receptors: Their distribution and function in body systems, and the implications for treating overactive bladder;Abrams;Br J Pharmacol,2006

5. Patient-reported reasons for discontinuing overactive bladder medication;Benner;BJU Int,2010

Cited by 90 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Long term safety, continuation rates and subjective and objective success of Posterior Tibial Nerve Stimulation for Overactive Bladder;Continence;2024-09

2. The history of the pharmacologic treatment of urgency incontinence;Continence Reports;2024-09

3. Mirabegron 50 mg once daily, long-term treatment maximizes benefit in middle-aged and older people with overactive bladder syndrome: a systematic review and meta-analysis of nine phase II/III, randomized, double-blind, parallel-design, placebo-controlled, multicenter, and multinational trials;Frontiers in Surgery;2024-08-26

4. Emerging therapies for overactive bladder: preclinical, phase I and phase II studies;Expert Opinion on Investigational Drugs;2024-05-09

5. Effect of Mirabegron in Men With Overactive Bladder and Erectile Dysfunction: A Prospective Observational Study;Cureus;2024-04-13